Résumé
Purpose. - Fifty percents of cancer arise in people older than 65 year-old. Most clinical trials in cancer treatment are limited in patients younger than 65 year-old. We review literature describing particularity of cancer treatment in elderly patients. Current knowledge and key points. - Therapeutic decisions should be based on an estimation of the patient's life expectancy, and risks and benefits should be weighted up accordingly. Geriatric oncology is made of a geriatric evaluation of patient and of knowledge of clinical trial about elderly patients. Future prospects and projects. - We present in this issue the principle of geriatric evaluation and the results of recent clinical trial on elderly cancer patients.
Titre traduit de la contribution | Treatment of cancer and hematological malignancy in elderly people (Part I) |
---|---|
langue originale | Français |
Pages (de - à) | 216-225 |
Nombre de pages | 10 |
journal | Revue de Medecine Interne |
Volume | 26 |
Numéro de publication | 3 |
Les DOIs | |
état | Publié - 1 janv. 2005 |
mots-clés
- Cancer
- Elderly patients
- Treatment